IRONWOOD INVESTMENT MANAGEMENT LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 173 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.

Quarter-by-quarter ownership
IRONWOOD INVESTMENT MANAGEMENT LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$373,320
-32.4%
18,096
-3.3%
0.23%
-28.3%
Q2 2023$552,398
+27.6%
18,719
-0.4%
0.32%
+17.3%
Q1 2023$433,060
-18.7%
18,796
-1.8%
0.27%
-22.8%
Q4 2022$532,534
-12.8%
19,149
-3.8%
0.35%
-17.8%
Q3 2022$611,000
+4.6%
19,908
+0.3%
0.43%
+9.5%
Q2 2022$584,000
-8.5%
19,856
+0.1%
0.39%
+12.4%
Q1 2022$638,000
-26.2%
19,842
+2.4%
0.35%
-18.7%
Q4 2021$864,000
-10.3%
19,383
+1.5%
0.43%
-14.4%
Q3 2021$963,000
-35.6%
19,093
+0.1%
0.50%
-33.9%
Q2 2021$1,496,000
+34.2%
19,074
-2.3%
0.76%
+28.2%
Q1 2021$1,115,000
-31.3%
19,520
+0.8%
0.59%
-38.0%
Q4 2020$1,622,000
+127.2%
19,365
-2.8%
0.95%
+86.3%
Q3 2020$714,000
+47.8%
19,918
-0.2%
0.51%
+35.6%
Q2 2020$483,000
+37.6%
19,958
-0.6%
0.38%
+7.1%
Q1 2020$351,000
-3.3%
20,070
-3.6%
0.35%
+39.8%
Q4 2019$363,000
+5.2%
20,811
-7.5%
0.25%
-3.1%
Q3 2019$345,000
-26.4%
22,507
-0.4%
0.26%
-29.2%
Q2 2019$469,000
-10.7%
22,595
-0.1%
0.37%
-14.1%
Q1 2019$525,000
+151.2%
22,607
+124.0%
0.43%
+120.7%
Q4 2018$209,00010,0920.19%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders